Brennan M
North London Blood Transfusion Centre, UK.
Blood Rev. 1991 Dec;5(4):240-4. doi: 10.1016/0268-960x(91)90015-5.
Fibrin glue is a topical biological adhesive, the effect of which imitates the final stages of coagulation. The glue consists of a solution of concentrated human fibrinogen which is activated by the addition of bovine thrombin and calcium chloride. The resultant clot aids haemostasis and tissue sealing and is completely absorbed during wound healing without foreign body reaction or extensive fibrosis. The fibrinogen component of fibrin glue can be produced from fresh frozen plasma obtained from single unit donations thereby reducing the risks of transfusion transmitted infections encountered by exposure to pools from large numbers of donors. Methods involving precipitation of fibrinogen by cryoprecipitation, polyethylene glycol or ammonium sulphate have been described and evaluated. The risk of transmission of infection can be further reduced by using plasma from 'accredited donors' who are plasma donors regularly tested for ALT and markers of viral infection or by use of fibrinogen prepared in advance of surgery from autologous blood. The second component, a mixture of thrombin and CaCl2, is quantitatively and qualitatively well defined and commercially available (Armour Pharmaceutical Co., Thrombinar (bovine thrombin]. Thrombin is applied to the operation site simultaneously and in equal volume to the fibrinogen but from a separate syringe. In the UK a commercial heat treated fibrin glue prepared from pooled plasma is available on a doctor/named patient basis (Tisseel, Immuno, Vienna). The haemostatic and adhesive properties of fibrin glue can be employed in virtually every surgical specialty. The usefulness of the glue is particularly well documented in the fields of cardiovascular surgery, ENT and neurosurgery.(ABSTRACT TRUNCATED AT 250 WORDS)
纤维蛋白胶是一种局部生物粘合剂,其作用模仿凝血的最后阶段。该胶水由浓缩人纤维蛋白原溶液组成,通过添加牛凝血酶和氯化钙来激活。形成的凝块有助于止血和组织封闭,在伤口愈合过程中会被完全吸收,不会产生异物反应或广泛纤维化。纤维蛋白胶的纤维蛋白原成分可从单单位捐赠获得的新鲜冷冻血浆中制备,从而降低因接触大量献血者的混合血浆而遇到的输血传播感染风险。已经描述并评估了通过冷沉淀、聚乙二醇或硫酸铵沉淀纤维蛋白原的方法。通过使用来自“认可献血者”的血浆(这些献血者是定期检测谷丙转氨酶和病毒感染标志物的血浆捐献者)或使用术前从自体血液制备的纤维蛋白原,可以进一步降低感染传播风险。第二种成分是凝血酶和氯化钙的混合物,在数量和质量上都有明确规定且可商购(阿莫尔制药公司,凝血酶原(牛凝血酶))。凝血酶与纤维蛋白原同时以相同体积但从单独的注射器施加到手术部位。在英国,一种由混合血浆制备的商业热处理纤维蛋白胶可在医生/指定患者的基础上获得(Tisseel,Immuno,维也纳)。纤维蛋白胶的止血和粘合特性几乎可用于每个外科专业。该胶水的实用性在心血管外科、耳鼻喉科和神经外科领域有特别充分的记录。(摘要截断于250字)